tradingkey.logo

Valneva Provides Update On Recommendation For Use Of Its Chikungunya Vaccine By French Authorities

ReutersApr 26, 2025 5:45 PM

- Valneva SE VLS.PA:

  • VALNEVA PROVIDES UPDATE ON RECOMMENDATION FOR USE OF ITS CHIKUNGUNYA VACCINE BY FRENCH AUTHORITIES

  • VALNEVA SE: ON APRIL 25, FRENCH HEALTH AUTHORITIES DECIDED TO SUSPEND USE OF IXCHIQ® IN PERSONS AGED 65 YEARS AND OLDER PENDING FURTHER INVESTIGATION

  • VALNEVA SE - THREE SAES, INCLUDING ONE DEATH, REPORTED AFTER IXCHIQ VACCINATION

  • VALNEVA SE - HAS MAINTAINS IXCHIQ RECOMMENDATION FOR AGES 18-64

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI